nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP1A2—Imiquimod—skin cancer	0.0739	0.0915	CbGbCtD
Azelastine—CYP1A1—Dacarbazine—skin cancer	0.0695	0.086	CbGbCtD
Azelastine—CYP2C8—Vismodegib—skin cancer	0.0662	0.082	CbGbCtD
Azelastine—CYP2C19—Vismodegib—skin cancer	0.0555	0.0688	CbGbCtD
Azelastine—CYP2E1—Dacarbazine—skin cancer	0.0537	0.0665	CbGbCtD
Azelastine—CYP2A6—Fluorouracil—skin cancer	0.0477	0.059	CbGbCtD
Azelastine—CYP2C9—Vismodegib—skin cancer	0.0461	0.0572	CbGbCtD
Azelastine—ABCB1—Vismodegib—skin cancer	0.0448	0.0555	CbGbCtD
Azelastine—CYP1A2—Vemurafenib—skin cancer	0.0405	0.0501	CbGbCtD
Azelastine—CYP3A4—Temozolomide—skin cancer	0.0387	0.0479	CbGbCtD
Azelastine—CYP3A4—Imiquimod—skin cancer	0.0387	0.0479	CbGbCtD
Azelastine—CYP2D6—Vemurafenib—skin cancer	0.0334	0.0413	CbGbCtD
Azelastine—CYP1A2—Dacarbazine—skin cancer	0.031	0.0384	CbGbCtD
Azelastine—CYP3A4—Vismodegib—skin cancer	0.0268	0.0332	CbGbCtD
Azelastine—ABCB1—Dactinomycin—skin cancer	0.0235	0.0291	CbGbCtD
Azelastine—CYP2C8—Fluorouracil—skin cancer	0.0235	0.0291	CbGbCtD
Azelastine—CYP3A4—Vemurafenib—skin cancer	0.0212	0.0263	CbGbCtD
Azelastine—CYP3A5—Docetaxel—skin cancer	0.0187	0.0231	CbGbCtD
Azelastine—CYP1A2—Fluorouracil—skin cancer	0.0182	0.0225	CbGbCtD
Azelastine—CYP2C9—Fluorouracil—skin cancer	0.0164	0.0203	CbGbCtD
Azelastine—ABCB1—Docetaxel—skin cancer	0.0121	0.015	CbGbCtD
Azelastine—CYP3A4—Docetaxel—skin cancer	0.00728	0.00901	CbGbCtD
Azelastine—Arthritis—Bleomycin—skin cancer	0.000832	0.00438	CcSEcCtD
Azelastine—Sinusitis—Imiquimod—skin cancer	0.000823	0.00433	CcSEcCtD
Azelastine—Abnormal vision—Temozolomide—skin cancer	0.000819	0.00431	CcSEcCtD
Azelastine—Mental disability—Temozolomide—skin cancer	0.000815	0.00429	CcSEcCtD
Azelastine—Rhinitis—Imiquimod—skin cancer	0.000789	0.00415	CcSEcCtD
Azelastine—Dysgeusia—Vemurafenib—skin cancer	0.000787	0.00414	CcSEcCtD
Azelastine—Pharyngitis—Imiquimod—skin cancer	0.000781	0.00411	CcSEcCtD
Azelastine—Back pain—Vemurafenib—skin cancer	0.000777	0.00409	CcSEcCtD
Azelastine—Ageusia—Docetaxel—skin cancer	0.000771	0.00406	CcSEcCtD
Azelastine—Gastroenteritis—Temozolomide—skin cancer	0.000769	0.00405	CcSEcCtD
Azelastine—Asthenia—Vismodegib—skin cancer	0.000762	0.00401	CcSEcCtD
Azelastine—Visual impairment—Imiquimod—skin cancer	0.000759	0.00399	CcSEcCtD
Azelastine—Eye pain—Temozolomide—skin cancer	0.000755	0.00398	CcSEcCtD
Azelastine—Pruritus—Vismodegib—skin cancer	0.000751	0.00395	CcSEcCtD
Azelastine—Eye disorder—Imiquimod—skin cancer	0.000736	0.00387	CcSEcCtD
Azelastine—Flushing—Imiquimod—skin cancer	0.000731	0.00385	CcSEcCtD
Azelastine—Diarrhoea—Vismodegib—skin cancer	0.000726	0.00382	CcSEcCtD
Azelastine—Amenorrhoea—Docetaxel—skin cancer	0.000711	0.00374	CcSEcCtD
Azelastine—Cough—Vemurafenib—skin cancer	0.000701	0.00369	CcSEcCtD
Azelastine—Bronchospasm—Bleomycin—skin cancer	0.000687	0.00362	CcSEcCtD
Azelastine—Myalgia—Vemurafenib—skin cancer	0.000684	0.0036	CcSEcCtD
Azelastine—Lacrimation increased—Docetaxel—skin cancer	0.000678	0.00357	CcSEcCtD
Azelastine—Vomiting—Vismodegib—skin cancer	0.000675	0.00355	CcSEcCtD
Azelastine—Rash—Vismodegib—skin cancer	0.000669	0.00352	CcSEcCtD
Azelastine—Dermatitis—Vismodegib—skin cancer	0.000669	0.00352	CcSEcCtD
Azelastine—Back pain—Imiquimod—skin cancer	0.000663	0.00349	CcSEcCtD
Azelastine—Face oedema—Temozolomide—skin cancer	0.000658	0.00347	CcSEcCtD
Azelastine—Anaphylactic shock—Vemurafenib—skin cancer	0.000656	0.00345	CcSEcCtD
Azelastine—Infection—Vemurafenib—skin cancer	0.000651	0.00343	CcSEcCtD
Azelastine—Ill-defined disorder—Imiquimod—skin cancer	0.000636	0.00335	CcSEcCtD
Azelastine—Nausea—Vismodegib—skin cancer	0.00063	0.00332	CcSEcCtD
Azelastine—Agitation—Imiquimod—skin cancer	0.00063	0.00331	CcSEcCtD
Azelastine—Malaise—Imiquimod—skin cancer	0.000618	0.00325	CcSEcCtD
Azelastine—Influenza like illness—Docetaxel—skin cancer	0.000607	0.00319	CcSEcCtD
Azelastine—Palpitations—Imiquimod—skin cancer	0.000606	0.00319	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Temozolomide—skin cancer	0.000601	0.00317	CcSEcCtD
Azelastine—Cough—Imiquimod—skin cancer	0.000598	0.00315	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000597	0.00315	CcSEcCtD
Azelastine—Haematuria—Bleomycin—skin cancer	0.000594	0.00313	CcSEcCtD
Azelastine—Hypertension—Imiquimod—skin cancer	0.000592	0.00311	CcSEcCtD
Azelastine—Chest pain—Imiquimod—skin cancer	0.000583	0.00307	CcSEcCtD
Azelastine—Myalgia—Imiquimod—skin cancer	0.000583	0.00307	CcSEcCtD
Azelastine—Anxiety—Imiquimod—skin cancer	0.000581	0.00306	CcSEcCtD
Azelastine—Discomfort—Imiquimod—skin cancer	0.000576	0.00303	CcSEcCtD
Azelastine—Dry mouth—Imiquimod—skin cancer	0.000571	0.003	CcSEcCtD
Azelastine—Bronchitis—Temozolomide—skin cancer	0.000567	0.00298	CcSEcCtD
Azelastine—Fatigue—Vemurafenib—skin cancer	0.000565	0.00298	CcSEcCtD
Azelastine—Nasopharyngitis—Fluorouracil—skin cancer	0.000562	0.00296	CcSEcCtD
Azelastine—Constipation—Vemurafenib—skin cancer	0.000561	0.00295	CcSEcCtD
Azelastine—Hypoaesthesia—Bleomycin—skin cancer	0.000556	0.00293	CcSEcCtD
Azelastine—Infection—Imiquimod—skin cancer	0.000556	0.00292	CcSEcCtD
Azelastine—Upper respiratory tract infection—Temozolomide—skin cancer	0.000548	0.00288	CcSEcCtD
Azelastine—Tachycardia—Imiquimod—skin cancer	0.000546	0.00287	CcSEcCtD
Azelastine—Pollakiuria—Temozolomide—skin cancer	0.000544	0.00287	CcSEcCtD
Azelastine—Weight increased—Temozolomide—skin cancer	0.000536	0.00282	CcSEcCtD
Azelastine—Flushing—Bleomycin—skin cancer	0.000519	0.00273	CcSEcCtD
Azelastine—Body temperature increased—Vemurafenib—skin cancer	0.000518	0.00273	CcSEcCtD
Azelastine—Pharyngitis—Dactinomycin—skin cancer	0.000518	0.00272	CcSEcCtD
Azelastine—HRH1—nose—skin cancer	0.000516	0.195	CbGeAlD
Azelastine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000509	0.00268	CcSEcCtD
Azelastine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000505	0.00266	CcSEcCtD
Azelastine—Paraesthesia—Imiquimod—skin cancer	0.000502	0.00264	CcSEcCtD
Azelastine—Dyspnoea—Imiquimod—skin cancer	0.000499	0.00262	CcSEcCtD
Azelastine—Somnolence—Imiquimod—skin cancer	0.000497	0.00262	CcSEcCtD
Azelastine—Sinusitis—Temozolomide—skin cancer	0.000493	0.0026	CcSEcCtD
Azelastine—Flushing—Dactinomycin—skin cancer	0.000484	0.00255	CcSEcCtD
Azelastine—Hypersensitivity—Vemurafenib—skin cancer	0.000483	0.00254	CcSEcCtD
Azelastine—Fatigue—Imiquimod—skin cancer	0.000482	0.00254	CcSEcCtD
Azelastine—Atrial fibrillation—Docetaxel—skin cancer	0.000478	0.00252	CcSEcCtD
Azelastine—Pain—Imiquimod—skin cancer	0.000478	0.00252	CcSEcCtD
Azelastine—Conjunctivitis—Fluorouracil—skin cancer	0.000471	0.00248	CcSEcCtD
Azelastine—Asthenia—Vemurafenib—skin cancer	0.00047	0.00248	CcSEcCtD
Azelastine—Hypoaesthesia—Temozolomide—skin cancer	0.000469	0.00247	CcSEcCtD
Azelastine—Pharyngitis—Temozolomide—skin cancer	0.000468	0.00246	CcSEcCtD
Azelastine—Pruritus—Vemurafenib—skin cancer	0.000464	0.00244	CcSEcCtD
Azelastine—Feeling abnormal—Imiquimod—skin cancer	0.000461	0.00243	CcSEcCtD
Azelastine—Gastrointestinal pain—Imiquimod—skin cancer	0.000457	0.00241	CcSEcCtD
Azelastine—Epistaxis—Fluorouracil—skin cancer	0.000457	0.0024	CcSEcCtD
Azelastine—Visual impairment—Temozolomide—skin cancer	0.000455	0.00239	CcSEcCtD
Azelastine—Sinusitis—Fluorouracil—skin cancer	0.000454	0.00239	CcSEcCtD
Azelastine—Ill-defined disorder—Bleomycin—skin cancer	0.000452	0.00238	CcSEcCtD
Azelastine—Diarrhoea—Vemurafenib—skin cancer	0.000449	0.00236	CcSEcCtD
Azelastine—Body temperature increased—Imiquimod—skin cancer	0.000442	0.00233	CcSEcCtD
Azelastine—Abdominal pain—Imiquimod—skin cancer	0.000442	0.00233	CcSEcCtD
Azelastine—Eye disorder—Temozolomide—skin cancer	0.000441	0.00232	CcSEcCtD
Azelastine—Malaise—Bleomycin—skin cancer	0.000439	0.00231	CcSEcCtD
Azelastine—Flushing—Temozolomide—skin cancer	0.000438	0.0023	CcSEcCtD
Azelastine—Rhinitis—Fluorouracil—skin cancer	0.000436	0.00229	CcSEcCtD
Azelastine—Dizziness—Vemurafenib—skin cancer	0.000434	0.00228	CcSEcCtD
Azelastine—Hypoaesthesia—Fluorouracil—skin cancer	0.000432	0.00228	CcSEcCtD
Azelastine—Pharyngitis—Fluorouracil—skin cancer	0.000431	0.00227	CcSEcCtD
Azelastine—Cough—Bleomycin—skin cancer	0.000425	0.00224	CcSEcCtD
Azelastine—Ill-defined disorder—Dactinomycin—skin cancer	0.000421	0.00222	CcSEcCtD
Azelastine—Vomiting—Vemurafenib—skin cancer	0.000417	0.00219	CcSEcCtD
Azelastine—Myalgia—Bleomycin—skin cancer	0.000414	0.00218	CcSEcCtD
Azelastine—Chest pain—Bleomycin—skin cancer	0.000414	0.00218	CcSEcCtD
Azelastine—Rash—Vemurafenib—skin cancer	0.000413	0.00218	CcSEcCtD
Azelastine—Dermatitis—Vemurafenib—skin cancer	0.000413	0.00217	CcSEcCtD
Azelastine—Hypersensitivity—Imiquimod—skin cancer	0.000412	0.00217	CcSEcCtD
Azelastine—Headache—Vemurafenib—skin cancer	0.000411	0.00216	CcSEcCtD
Azelastine—Discomfort—Bleomycin—skin cancer	0.000409	0.00216	CcSEcCtD
Azelastine—Malaise—Dactinomycin—skin cancer	0.000409	0.00216	CcSEcCtD
Azelastine—Nasopharyngitis—Docetaxel—skin cancer	0.000405	0.00213	CcSEcCtD
Azelastine—Dysgeusia—Temozolomide—skin cancer	0.000402	0.00212	CcSEcCtD
Azelastine—Asthenia—Imiquimod—skin cancer	0.000401	0.00211	CcSEcCtD
Azelastine—Confusional state—Bleomycin—skin cancer	0.000401	0.00211	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.0004	0.00211	CcSEcCtD
Azelastine—Anaphylactic shock—Bleomycin—skin cancer	0.000397	0.00209	CcSEcCtD
Azelastine—Back pain—Temozolomide—skin cancer	0.000397	0.00209	CcSEcCtD
Azelastine—Pruritus—Imiquimod—skin cancer	0.000396	0.00208	CcSEcCtD
Azelastine—Infection—Bleomycin—skin cancer	0.000395	0.00208	CcSEcCtD
Azelastine—Nausea—Vemurafenib—skin cancer	0.000389	0.00205	CcSEcCtD
Azelastine—Vision blurred—Temozolomide—skin cancer	0.000387	0.00204	CcSEcCtD
Azelastine—Myalgia—Dactinomycin—skin cancer	0.000387	0.00203	CcSEcCtD
Azelastine—Bronchospasm—Docetaxel—skin cancer	0.000385	0.00203	CcSEcCtD
Azelastine—Diarrhoea—Imiquimod—skin cancer	0.000383	0.00201	CcSEcCtD
Azelastine—Discomfort—Dactinomycin—skin cancer	0.000382	0.00201	CcSEcCtD
Azelastine—Ill-defined disorder—Temozolomide—skin cancer	0.000381	0.00201	CcSEcCtD
Azelastine—Agitation—Temozolomide—skin cancer	0.000377	0.00199	CcSEcCtD
Azelastine—Malaise—Temozolomide—skin cancer	0.00037	0.00195	CcSEcCtD
Azelastine—Dizziness—Imiquimod—skin cancer	0.00037	0.00195	CcSEcCtD
Azelastine—Vertigo—Temozolomide—skin cancer	0.000369	0.00194	CcSEcCtD
Azelastine—Infection—Dactinomycin—skin cancer	0.000368	0.00194	CcSEcCtD
Azelastine—Palpitations—Temozolomide—skin cancer	0.000363	0.00191	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000362	0.00191	CcSEcCtD
Azelastine—Cough—Temozolomide—skin cancer	0.000358	0.00189	CcSEcCtD
Azelastine—Paraesthesia—Bleomycin—skin cancer	0.000357	0.00188	CcSEcCtD
Azelastine—Weight increased—Docetaxel—skin cancer	0.000357	0.00188	CcSEcCtD
Azelastine—Vision blurred—Fluorouracil—skin cancer	0.000357	0.00188	CcSEcCtD
Azelastine—Vomiting—Imiquimod—skin cancer	0.000356	0.00187	CcSEcCtD
Azelastine—Hypertension—Temozolomide—skin cancer	0.000355	0.00187	CcSEcCtD
Azelastine—Dyspnoea—Bleomycin—skin cancer	0.000354	0.00186	CcSEcCtD
Azelastine—Rash—Imiquimod—skin cancer	0.000353	0.00186	CcSEcCtD
Azelastine—Dermatitis—Imiquimod—skin cancer	0.000352	0.00185	CcSEcCtD
Azelastine—Headache—Imiquimod—skin cancer	0.00035	0.00184	CcSEcCtD
Azelastine—Myalgia—Temozolomide—skin cancer	0.00035	0.00184	CcSEcCtD
Azelastine—Anxiety—Temozolomide—skin cancer	0.000348	0.00183	CcSEcCtD
Azelastine—Discomfort—Temozolomide—skin cancer	0.000345	0.00182	CcSEcCtD
Azelastine—Dry mouth—Temozolomide—skin cancer	0.000342	0.0018	CcSEcCtD
Azelastine—Pain—Bleomycin—skin cancer	0.00034	0.00179	CcSEcCtD
Azelastine—Conjunctivitis—Docetaxel—skin cancer	0.00034	0.00179	CcSEcCtD
Azelastine—Confusional state—Temozolomide—skin cancer	0.000338	0.00178	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000338	0.00178	CcSEcCtD
Azelastine—Anaphylactic shock—Temozolomide—skin cancer	0.000335	0.00176	CcSEcCtD
Azelastine—Infection—Temozolomide—skin cancer	0.000333	0.00175	CcSEcCtD
Azelastine—Nausea—Imiquimod—skin cancer	0.000332	0.00175	CcSEcCtD
Azelastine—Epistaxis—Docetaxel—skin cancer	0.00033	0.00174	CcSEcCtD
Azelastine—Feeling abnormal—Bleomycin—skin cancer	0.000327	0.00172	CcSEcCtD
Azelastine—Chest pain—Fluorouracil—skin cancer	0.000322	0.0017	CcSEcCtD
Azelastine—Myalgia—Fluorouracil—skin cancer	0.000322	0.0017	CcSEcCtD
Azelastine—Fatigue—Dactinomycin—skin cancer	0.000319	0.00168	CcSEcCtD
Azelastine—Discomfort—Fluorouracil—skin cancer	0.000318	0.00168	CcSEcCtD
Azelastine—Pain—Dactinomycin—skin cancer	0.000317	0.00167	CcSEcCtD
Azelastine—Rhinitis—Docetaxel—skin cancer	0.000314	0.00166	CcSEcCtD
Azelastine—Body temperature increased—Bleomycin—skin cancer	0.000314	0.00165	CcSEcCtD
Azelastine—Hypoaesthesia—Docetaxel—skin cancer	0.000312	0.00164	CcSEcCtD
Azelastine—Confusional state—Fluorouracil—skin cancer	0.000311	0.00164	CcSEcCtD
Azelastine—Pharyngitis—Docetaxel—skin cancer	0.000311	0.00164	CcSEcCtD
Azelastine—Anaphylactic shock—Fluorouracil—skin cancer	0.000309	0.00163	CcSEcCtD
Azelastine—Infection—Fluorouracil—skin cancer	0.000307	0.00161	CcSEcCtD
Azelastine—Feeling abnormal—Dactinomycin—skin cancer	0.000305	0.00161	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000305	0.00161	CcSEcCtD
Azelastine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000303	0.00159	CcSEcCtD
Azelastine—Visual impairment—Docetaxel—skin cancer	0.000302	0.00159	CcSEcCtD
Azelastine—Tachycardia—Fluorouracil—skin cancer	0.000301	0.00159	CcSEcCtD
Azelastine—Paraesthesia—Temozolomide—skin cancer	0.000301	0.00158	CcSEcCtD
Azelastine—Dyspnoea—Temozolomide—skin cancer	0.000299	0.00157	CcSEcCtD
Azelastine—Somnolence—Temozolomide—skin cancer	0.000298	0.00157	CcSEcCtD
Azelastine—Eye disorder—Docetaxel—skin cancer	0.000293	0.00154	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—skin cancer	0.000293	0.00154	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—skin cancer	0.000293	0.00154	CcSEcCtD
Azelastine—Hypersensitivity—Bleomycin—skin cancer	0.000293	0.00154	CcSEcCtD
Azelastine—Flushing—Docetaxel—skin cancer	0.000291	0.00153	CcSEcCtD
Azelastine—Fatigue—Temozolomide—skin cancer	0.000289	0.00152	CcSEcCtD
Azelastine—Pain—Temozolomide—skin cancer	0.000287	0.00151	CcSEcCtD
Azelastine—Constipation—Temozolomide—skin cancer	0.000287	0.00151	CcSEcCtD
Azelastine—Asthenia—Bleomycin—skin cancer	0.000285	0.0015	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000281	0.00148	CcSEcCtD
Azelastine—Pruritus—Bleomycin—skin cancer	0.000281	0.00148	CcSEcCtD
Azelastine—Paraesthesia—Fluorouracil—skin cancer	0.000277	0.00146	CcSEcCtD
Azelastine—Feeling abnormal—Temozolomide—skin cancer	0.000276	0.00145	CcSEcCtD
Azelastine—Dyspnoea—Fluorouracil—skin cancer	0.000275	0.00145	CcSEcCtD
Azelastine—Somnolence—Fluorouracil—skin cancer	0.000275	0.00145	CcSEcCtD
Azelastine—Gastrointestinal pain—Temozolomide—skin cancer	0.000274	0.00144	CcSEcCtD
Azelastine—Hypersensitivity—Dactinomycin—skin cancer	0.000273	0.00144	CcSEcCtD
Azelastine—Dysgeusia—Docetaxel—skin cancer	0.000267	0.00141	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—skin cancer	0.000266	0.0014	CcSEcCtD
Azelastine—Body temperature increased—Temozolomide—skin cancer	0.000265	0.00139	CcSEcCtD
Azelastine—Abdominal pain—Temozolomide—skin cancer	0.000265	0.00139	CcSEcCtD
Azelastine—Back pain—Docetaxel—skin cancer	0.000264	0.00139	CcSEcCtD
Azelastine—Pain—Fluorouracil—skin cancer	0.000264	0.00139	CcSEcCtD
Azelastine—Feeling abnormal—Fluorouracil—skin cancer	0.000254	0.00134	CcSEcCtD
Azelastine—Diarrhoea—Dactinomycin—skin cancer	0.000254	0.00133	CcSEcCtD
Azelastine—Vomiting—Bleomycin—skin cancer	0.000253	0.00133	CcSEcCtD
Azelastine—Rash—Bleomycin—skin cancer	0.00025	0.00132	CcSEcCtD
Azelastine—Dermatitis—Bleomycin—skin cancer	0.00025	0.00132	CcSEcCtD
Azelastine—Hypersensitivity—Temozolomide—skin cancer	0.000247	0.0013	CcSEcCtD
Azelastine—Body temperature increased—Fluorouracil—skin cancer	0.000244	0.00128	CcSEcCtD
Azelastine—Palpitations—Docetaxel—skin cancer	0.000241	0.00127	CcSEcCtD
Azelastine—Asthenia—Temozolomide—skin cancer	0.00024	0.00127	CcSEcCtD
Azelastine—Cough—Docetaxel—skin cancer	0.000238	0.00125	CcSEcCtD
Azelastine—Pruritus—Temozolomide—skin cancer	0.000237	0.00125	CcSEcCtD
Azelastine—Nausea—Bleomycin—skin cancer	0.000236	0.00124	CcSEcCtD
Azelastine—Hypertension—Docetaxel—skin cancer	0.000236	0.00124	CcSEcCtD
Azelastine—Vomiting—Dactinomycin—skin cancer	0.000236	0.00124	CcSEcCtD
Azelastine—Rash—Dactinomycin—skin cancer	0.000234	0.00123	CcSEcCtD
Azelastine—Chest pain—Docetaxel—skin cancer	0.000232	0.00122	CcSEcCtD
Azelastine—Myalgia—Docetaxel—skin cancer	0.000232	0.00122	CcSEcCtD
Azelastine—Diarrhoea—Temozolomide—skin cancer	0.000229	0.00121	CcSEcCtD
Azelastine—Hypersensitivity—Fluorouracil—skin cancer	0.000227	0.0012	CcSEcCtD
Azelastine—Dry mouth—Docetaxel—skin cancer	0.000227	0.0012	CcSEcCtD
Azelastine—Confusional state—Docetaxel—skin cancer	0.000225	0.00118	CcSEcCtD
Azelastine—Anaphylactic shock—Docetaxel—skin cancer	0.000223	0.00117	CcSEcCtD
Azelastine—Dizziness—Temozolomide—skin cancer	0.000222	0.00117	CcSEcCtD
Azelastine—Infection—Docetaxel—skin cancer	0.000221	0.00117	CcSEcCtD
Azelastine—Nausea—Dactinomycin—skin cancer	0.00022	0.00116	CcSEcCtD
Azelastine—Pruritus—Fluorouracil—skin cancer	0.000218	0.00115	CcSEcCtD
Azelastine—Tachycardia—Docetaxel—skin cancer	0.000218	0.00115	CcSEcCtD
Azelastine—Vomiting—Temozolomide—skin cancer	0.000213	0.00112	CcSEcCtD
Azelastine—Rash—Temozolomide—skin cancer	0.000211	0.00111	CcSEcCtD
Azelastine—Diarrhoea—Fluorouracil—skin cancer	0.000211	0.00111	CcSEcCtD
Azelastine—Dermatitis—Temozolomide—skin cancer	0.000211	0.00111	CcSEcCtD
Azelastine—Headache—Temozolomide—skin cancer	0.00021	0.00111	CcSEcCtD
Azelastine—Dizziness—Fluorouracil—skin cancer	0.000204	0.00107	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000203	0.00107	CcSEcCtD
Azelastine—Paraesthesia—Docetaxel—skin cancer	0.0002	0.00105	CcSEcCtD
Azelastine—Nausea—Temozolomide—skin cancer	0.000199	0.00105	CcSEcCtD
Azelastine—Dyspnoea—Docetaxel—skin cancer	0.000199	0.00105	CcSEcCtD
Azelastine—Somnolence—Docetaxel—skin cancer	0.000198	0.00104	CcSEcCtD
Azelastine—Vomiting—Fluorouracil—skin cancer	0.000196	0.00103	CcSEcCtD
Azelastine—Rash—Fluorouracil—skin cancer	0.000195	0.00102	CcSEcCtD
Azelastine—Dermatitis—Fluorouracil—skin cancer	0.000195	0.00102	CcSEcCtD
Azelastine—Headache—Fluorouracil—skin cancer	0.000193	0.00102	CcSEcCtD
Azelastine—Fatigue—Docetaxel—skin cancer	0.000192	0.00101	CcSEcCtD
Azelastine—Pain—Docetaxel—skin cancer	0.000191	0.001	CcSEcCtD
Azelastine—Constipation—Docetaxel—skin cancer	0.000191	0.001	CcSEcCtD
Azelastine—Feeling abnormal—Docetaxel—skin cancer	0.000184	0.000967	CcSEcCtD
Azelastine—Nausea—Fluorouracil—skin cancer	0.000183	0.000966	CcSEcCtD
Azelastine—CYP1A1—skin epidermis—skin cancer	0.000183	0.0692	CbGeAlD
Azelastine—Gastrointestinal pain—Docetaxel—skin cancer	0.000182	0.000959	CcSEcCtD
Azelastine—Body temperature increased—Docetaxel—skin cancer	0.000176	0.000927	CcSEcCtD
Azelastine—Abdominal pain—Docetaxel—skin cancer	0.000176	0.000927	CcSEcCtD
Azelastine—Hypersensitivity—Docetaxel—skin cancer	0.000164	0.000864	CcSEcCtD
Azelastine—Asthenia—Docetaxel—skin cancer	0.00016	0.000842	CcSEcCtD
Azelastine—Pruritus—Docetaxel—skin cancer	0.000158	0.00083	CcSEcCtD
Azelastine—Diarrhoea—Docetaxel—skin cancer	0.000152	0.000803	CcSEcCtD
Azelastine—HRH3—head—skin cancer	0.000152	0.0573	CbGeAlD
Azelastine—Dizziness—Docetaxel—skin cancer	0.000147	0.000776	CcSEcCtD
Azelastine—Vomiting—Docetaxel—skin cancer	0.000142	0.000746	CcSEcCtD
Azelastine—Rash—Docetaxel—skin cancer	0.000141	0.00074	CcSEcCtD
Azelastine—Dermatitis—Docetaxel—skin cancer	0.00014	0.000739	CcSEcCtD
Azelastine—Headache—Docetaxel—skin cancer	0.00014	0.000735	CcSEcCtD
Azelastine—Nausea—Docetaxel—skin cancer	0.000132	0.000697	CcSEcCtD
Azelastine—KCNH2—nipple—skin cancer	0.000105	0.0396	CbGeAlD
Azelastine—CYP1A2—nipple—skin cancer	8.97e-05	0.0339	CbGeAlD
Azelastine—CYP1A1—nipple—skin cancer	8.85e-05	0.0335	CbGeAlD
Azelastine—HRH1—nipple—skin cancer	8.4e-05	0.0318	CbGeAlD
Azelastine—ADRA1B—head—skin cancer	8.07e-05	0.0305	CbGeAlD
Azelastine—ABCB1—blood vessel—skin cancer	6.36e-05	0.0241	CbGeAlD
Azelastine—CYP1A1—epithelium—skin cancer	5.96e-05	0.0225	CbGeAlD
Azelastine—HRH1—connective tissue—skin cancer	5.96e-05	0.0225	CbGeAlD
Azelastine—CYP1A1—skin of body—skin cancer	5.67e-05	0.0214	CbGeAlD
Azelastine—HRH1—epithelium—skin cancer	5.66e-05	0.0214	CbGeAlD
Azelastine—CYP2B6—skin of body—skin cancer	5.51e-05	0.0208	CbGeAlD
Azelastine—KCNH2—female reproductive system—skin cancer	5.24e-05	0.0198	CbGeAlD
Azelastine—CYP1A1—mammalian vulva—skin cancer	5.17e-05	0.0196	CbGeAlD
Azelastine—HRH1—mammalian vulva—skin cancer	4.91e-05	0.0186	CbGeAlD
Azelastine—CYP2C8—female reproductive system—skin cancer	4.8e-05	0.0181	CbGeAlD
Azelastine—CYP2B6—lymphoid tissue—skin cancer	4.46e-05	0.0169	CbGeAlD
Azelastine—CYP1A1—female reproductive system—skin cancer	4.43e-05	0.0167	CbGeAlD
Azelastine—KCNH2—head—skin cancer	4.38e-05	0.0166	CbGeAlD
Azelastine—CYP2B6—female reproductive system—skin cancer	4.3e-05	0.0163	CbGeAlD
Azelastine—CYP2C9—female reproductive system—skin cancer	4.26e-05	0.0161	CbGeAlD
Azelastine—HRH1—female reproductive system—skin cancer	4.2e-05	0.0159	CbGeAlD
Azelastine—CYP2E1—lymphoid tissue—skin cancer	4.19e-05	0.0158	CbGeAlD
Azelastine—CYP2E1—female reproductive system—skin cancer	4.04e-05	0.0153	CbGeAlD
Azelastine—CYP1A1—head—skin cancer	3.7e-05	0.014	CbGeAlD
Azelastine—CYP2B6—head—skin cancer	3.59e-05	0.0136	CbGeAlD
Azelastine—HRH1—head—skin cancer	3.51e-05	0.0133	CbGeAlD
Azelastine—CYP2E1—head—skin cancer	3.37e-05	0.0128	CbGeAlD
Azelastine—CYP3A4—female reproductive system—skin cancer	3.25e-05	0.0123	CbGeAlD
Azelastine—CYP2D6—female reproductive system—skin cancer	3.2e-05	0.0121	CbGeAlD
Azelastine—ABCB1—epithelium—skin cancer	3.1e-05	0.0117	CbGeAlD
Azelastine—KCNH2—lymph node—skin cancer	3.07e-05	0.0116	CbGeAlD
Azelastine—ABCB1—mammalian vulva—skin cancer	2.68e-05	0.0102	CbGeAlD
Azelastine—CYP2D6—head—skin cancer	2.67e-05	0.0101	CbGeAlD
Azelastine—CYP1A1—lymph node—skin cancer	2.59e-05	0.00979	CbGeAlD
Azelastine—HRH1—lymph node—skin cancer	2.46e-05	0.0093	CbGeAlD
Azelastine—ABCB1—lymphoid tissue—skin cancer	2.38e-05	0.00902	CbGeAlD
Azelastine—ABCB1—female reproductive system—skin cancer	2.3e-05	0.0087	CbGeAlD
Azelastine—ABCB1—head—skin cancer	1.92e-05	0.00727	CbGeAlD
Azelastine—ABCB1—lymph node—skin cancer	1.35e-05	0.00509	CbGeAlD
